Kineta, Inc., a clinical stage biotechnology company, develops immunotherapies for oncology, neuroscience, and biodefense. It serves private, government, and industry partners. The company has strategic partnerships with Pfizer, Genentech, Wellcome, and Samsung Biologics Co., Ltd. Kineta, Inc. was formerly known as Lecura, Inc. The company was incorporated in 2007 and is based in Seattle, Washington.
Kineta Dividend Announcement
• Kineta announced a annually dividend of $10.01 per ordinary share which will be made payable on 2022-12-19. Ex dividend date: 2022-12-19
• Kineta's trailing twelve-month (TTM) dividend yield is -%
Kineta Dividend History
Ex-Div date | Dividend amount | Dividend type | Pay date |
---|---|---|---|
2022-12-19 | $10.01 | annually | 2022-12-19 |
Kineta Dividend per year
Kineta Dividend Yield
Kineta current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing Kineta stock? Use our calculator to estimate your expected dividend yield:
Kineta Financial Ratios
Kineta Dividend FAQ
1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.
2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.
3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.
4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.
5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Place an order: Use the brokerage's trading platform to place an order to buy Kineta stock.
Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.